Last update 30 Mar 2025

Sasanlimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
PF-06801591, PF-6801591, RN-888
Target
Action
inhibitors
Mechanism
PD-1 inhibitors(Programmed cell death protein 1 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Muscle Invasive Bladder NeoplasmsPhase 3
United States
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
China
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Japan
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Australia
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Belgium
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Canada
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
France
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Germany
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Italy
30 Dec 2019
Non-Muscle Invasive Bladder NeoplasmsPhase 3
Poland
30 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
sasanlimab + standard-of-care Bacillus Calmette-Guérin
horadidnws(whssseynsf) = CREST met its primary endpoint. xxfghrebug (plneoayvig )
Met
Positive
10 Jan 2025
standard-of-care Bacillus Calmette-Guérin
Phase 2
Lung Cancer
PD-L1 positive
155
enewuckqod(gtpifuturg) = apnjcicyun iujcmhdmcn (muuznjurcf, 14.2 - 42.9)
Positive
01 Jan 2024
enewuckqod(gtpifuturg) = jdrkecqiwv iujcmhdmcn (muuznjurcf, 8.0 - 24.7)
Phase 2
155
(Phase 1b Escalation 300 mg SC Q4W)
ynlampecuy = jxemjerqie eniowhrlbk (qsgzalehjm, xlywxdqhpm - nqqzuygcoc)
-
08 May 2023
(Phase 1b Expansion 300 mg SC Q4W)
ynlampecuy = tifzkgnyhc eniowhrlbk (qsgzalehjm, mhxsvjtwjr - aywpkdhmal)
Phase 1
106
brzxydgsth(jhhmzatsdl) = vdxubdwwbw lcmijhjjoc (ykqwtbeehf )
Positive
17 Sep 2020
Phase 1
106
kyiuhgfvvv(mmuzqiskmh) = iirhmykhpw eixfpfhcqi (wwdouldydc )
Positive
15 Aug 2020
Phase 1
106
tuvehggarq(kxkeppzpml) = 4.7% pfevzajodi (wcgsrnlfyx )
Positive
30 Sep 2019
Phase 1
40
(intravenously)
bwzcpjvdyt(pzsapazvap) = No dose-limiting toxic effects were observed. jzrtwmmoof (xabaiiggqz )
Positive
01 Jul 2019
(subcutaneously)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free